These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37049340)

  • 1. Nanotechnology-Based Diagnostics for Diseases Prevalent in Developing Countries: Current Advances in Point-of-Care Tests.
    Thwala LN; Ndlovu SC; Mpofu KT; Lugongolo MY; Mthunzi-Kufa P
    Nanomaterials (Basel); 2023 Mar; 13(7):. PubMed ID: 37049340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.
    Kumar A; Parihar A; Panda U; Parihar DS
    ACS Appl Bio Mater; 2022 May; 5(5):2046-2068. PubMed ID: 35473316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.
    Duchesne L; Lacombe K
    J Viral Hepat; 2018 Feb; 25(2):108-117. PubMed ID: 29134742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.
    Jain S; Nehra M; Kumar R; Dilbaghi N; Hu T; Kumar S; Kaushik A; Li CZ
    Biosens Bioelectron; 2021 May; 179():113074. PubMed ID: 33596516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 6. Nucleic-acid testing, new platforms and nanotechnology for point-of-decision diagnosis of animal pathogens.
    Teles F; Fonseca L
    Methods Mol Biol; 2015; 1247():253-83. PubMed ID: 25399103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study.
    Hocking L; George J; Broberg EK; Struelens MJ; Leitmeyer KC; Deshpande A; Parkinson S; Francombe J; Morley KI; de Carvalho Gomes H
    Front Public Health; 2021; 9():722943. PubMed ID: 34746078
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing.
    Wang X; Li F; Guo Y
    Front Chem; 2020; 8():586702. PubMed ID: 33195085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic Point-of-Care Testing: Commercial Landscape and Future Directions.
    Sachdeva S; Davis RW; Saha AK
    Front Bioeng Biotechnol; 2020; 8():602659. PubMed ID: 33520958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing.
    O'Sullivan S; Ali Z; Jiang X; Abdolvand R; Ünlü MS; Silva HPD; Baca JT; Kim B; Scott S; Sajid MI; Moradian S; Mansoorzare H; Holzinger A
    Sensors (Basel); 2019 Apr; 19(8):. PubMed ID: 31018573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancement in POCT Molecular Testing: The Multiplex PCR POCT Devices for Infectious Diseases.
    Alp A
    EJIFCC; 2018 Nov; 29(3):205-209. PubMed ID: 30479605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of nanodiagnostics in point-of-care tests for infectious diseases.
    Wang Y; Yu L; Kong X; Sun L
    Int J Nanomedicine; 2017; 12():4789-4803. PubMed ID: 28740385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in point-of-care technologies for molecular diagnostics.
    Zarei M
    Biosens Bioelectron; 2017 Dec; 98():494-506. PubMed ID: 28728010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidics-based strategies for molecular diagnostics of infectious diseases.
    Wang X; Hong XZ; Li YW; Li Y; Wang J; Chen P; Liu BF
    Mil Med Res; 2022 Mar; 9(1):11. PubMed ID: 35300739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care Diagnostics for Farm Animal Diseases: From Biosensors to Integrated Lab-on-Chip Devices.
    Manessis G; Gelasakis AI; Bossis I
    Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients' Follow Up.
    Borriello M; Tarabella G; D'Angelo P; Liboà A; Barra M; Vurro D; Lombari P; Coppola A; Mazzella E; Perna AF; Ingrosso D
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care testing (POCT): Current techniques and future perspectives.
    Luppa PB; Müller C; Schlichtiger A; Schlebusch H
    Trends Analyt Chem; 2011 Jun; 30(6):887-898. PubMed ID: 32287536
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.